.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Covington
Accenture
Julphar
Colorcon
McKesson
Deloitte
US Department of Justice
Queensland Health

Generated: January 17, 2018

DrugPatentWatch Database Preview

Patents Expiring in September 2021

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpFARYDAKpanobinostat lactateCAPSULE;ORAL205353-003Feb 23, 2015RXYesYes➤ Subscribe➤ SubscribeYYTREATMENT OF MULTIPLE MYELOMA, IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE
Novartis Pharms CorpFARYDAKpanobinostat lactateCAPSULE;ORAL205353-002Feb 23, 2015RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF MULTIPLE MYELOMA, IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE
Novartis Pharms CorpFARYDAKpanobinostat lactateCAPSULE;ORAL205353-001Feb 23, 2015RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF MULTIPLE MYELOMA, IN COMBINATION WITH BORTEZOMIB AND DEXAMETHASONE
Spectrum PharmsBELEODAQbelinostatPOWDER;IV (INFUSION)206256-001Jul 3, 2014RXYesYes➤ Subscribe➤ SubscribeYYTREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA (PTCL).
Sanofi Aventis UsJEVTANA KITcabazitaxelSOLUTION;IV (INFUSION)201023-001Jun 17, 2010RXYesYes➤ Subscribe➤ SubscribeY
Sun Pharm Inds IncABSORICAisotretinoinCAPSULE;ORAL021951-001May 25, 2012BXRXYesNo➤ Subscribe➤ SubscribeY
Sun Pharm Inds IncABSORICAisotretinoinCAPSULE;ORAL021951-003May 25, 2012BXRXYesNo➤ Subscribe➤ SubscribeY
Sun Pharm Inds IncABSORICAisotretinoinCAPSULE;ORAL021951-004May 25, 2012BXRXYesYes➤ Subscribe➤ SubscribeY
Sun Pharm Inds IncABSORICAisotretinoinCAPSULE;ORAL021951-003May 25, 2012BXRXYesNo➤ Subscribe➤ SubscribeY
Sun Pharm Inds IncABSORICAisotretinoinCAPSULE;ORAL021951-005Aug 15, 2014RXYesNo➤ Subscribe➤ SubscribeTREATMENT OF A SKIN DISORDER
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Citi
Cipla
Express Scripts
Chubb
Deloitte
Federal Trade Commission
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot